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The acute nociceptive signals induced 
by bradykinin in rat sensory neurons are 
mediated by inhibition of M-type K+ channels 
and activation of Ca2+-activated Cl– channels
Boyi Liu,1,2 John E. Linley,2 Xiaona Du,1 Xuan Zhang,1  
Lezanne Ooi,2 Hailin Zhang,1 and Nikita Gamper2
1Department of Pharmacology, Hebei Medical University, Shijiazhuang, China. 2Institute of Membrane and Systems Biology,  
Faculty of Biological Science, University of Leeds, United Kingdom.
Bradykinin	(BK)	is	an	inflammatory	mediator	and	one	of	the	most	potent	endogenous	pain-inducing	sub-
stances.	When	released	at	sites	of	tissue	damage	or	inflammation,	or	applied	exogenously,	BK	produces	acute	
spontaneous	pain	and	causes	hyperalgesia	(increased	sensitivity	to	potentially	painful	stimuli).	The	mecha-
nisms	underlying	spontaneous	pain	induced	by	BK	are	poorly	understood.	Here	we	report	that	in	small	noci-
ceptive	neurons	from	rat	dorsal	root	ganglia,	BK,	acting	through	its	B2	receptors,	PLC,	and	release	of	calcium	
from	intracellular	stores,	robustly	inhibits	M-type	K+	channels	and	opens	Ca2+-activated	Cl–	channels	(CaCCs)	
encoded	by	Tmem16a	(also	known	as	Ano1).	Summation	of	these	two	effects	accounted	for	the	depolarization	
and	increase	in	AP	firing	induced	by	BK	in	DRG	neurons.	Local	injection	of	inhibitors	of	CaCC	and	specific	
M-channel	openers	both	strongly	attenuated	the	nociceptive	effect	of	local	injections	of	BK	in	rats.	These	
results	provide	a	framework	for	understanding	spontaneous	inflammatory	pain	and	may	suggest	new	drug	
targets	for	treatment	of	such	pain.
Introduction
Bradykinin (BK) has long been known as one of the most potent 
endogenous pain-inducing (algogenic) substances (1, 2), and it is 
a major inflammatory mediator (3). BK and related short peptides 
(kinins) are produced de novo at sites of injury or inflammation 
from their precursors, kininogens, by serine proteases such as tissue 
kallikrein or by proteases released from mast cells and basophils (4). 
Cellular effects of BK are mediated by specific receptors, B1 and B2. 
B1 receptors are usually absent from noninflamed tissues and have a 
low affinity for BK; thus, it is believed that the majority of the acute 
effects of BK are mediated by B2 receptors (B2Rs), which are G pro-
tein–coupled receptors acting via Gq/11 signaling cascades (5).
When applied exogenously to a human skin blister or inject-
ed into arteries supplying viscera in laboratory animals (1), BK 
induces two major effects: (a) severe spontaneous pain and (b) 
increased sensitivity to painful (hyperalgesia) and nonpainful 
(allodynia) thermal and mechanical stimuli (2, 5). The latter effect 
has attracted considerable attention and is now relatively well 
understood. It is believed that B2R activation induces sensitiza-
tion of sensory ion channels, including TRPV1 (6) and TRPA1 (7). 
Additional mechanisms for BK-induced hyperalgesia are medi-
ated by PKCε (8), which in turn also causes TRPV1 sensitization 
(9). Unfortunately, the understanding of the molecular events 
underlying acute pain directly induced by BK is not that advanced 
and is mostly based on the electrophysiological observations of 
BK-induced depolarization (10, 11), increased action potential 
(AP) firing (12), and inward current induction (10, 12). BK has 
been referred to as “the most potent endogenous algogenic sub-
stance known” (2); thus, the elucidation of its modes and mecha-
nisms of action should improve our ability to understand and 
treat spontaneous inflammatory pain.
The aim of this study was to investigate the mechanisms of acute 
nociceptive signaling induced by BK. We characterized the major 
membrane currents directly affected by BK in nociceptive sensory 
neurons of dorsal root ganglia (DRG), investigated their molecular 
identities, the signaling cascades that regulate them, and their con-
tribution to neuronal excitability and to BK-induced nocifensive 
behavior in rats. Our findings indicate that the major effects of 
BK on the excitability of nociceptors are mediated by PLC- and 
Ca2+-dependent inhibition of M-type K+ channels and by simulta-
neous opening of Ca2+-activated Cl– channels (CaCCs) encoded by 
transmembrane protein 16A (Tmem16a). Both these effects con-
tribute to membrane depolarization in primary sensory afferents, 
resulting in the generation of ascending nociceptive signals. Thus, 
this study presents a step-by-step reconstitution of the molecular 
events of the acute nociceptive signal induced in the peripheral 
sensory system by BK. Our findings also put forward new candi-
date drug targets for the treatment of inflammatory pain.
Results
Signaling pathways triggered in DRG neurons by BK. It is well estab-
lished that the most abundant BK receptors, B2, couple to Gq/11 
and activate PLC (5). PLC hydrolyzes the plasma membrane 
phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) and 
releases inositol 1,4,5-trisphosphate (IP3) into the cytosol; the 
latter can then trigger exit of Ca2+ from IP3-sensitive intracellular 
stores. Both PIP2 depletion and Ca2+ release are powerful signaling 
events capable of regulating neuronal ion channels. However, Ca2+ 
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release after PLC activation does not always occur; likewise, local-
ized hydrolysis of PIP2 does not always lead to a global drop in the 
membrane PIP2 level (13, 14). Our initial approach was therefore 
to examine these first steps of the BK signaling cascade in DRG.
In the first series of experiments, we transfected DRG neurons 
with PLCδ-PH-GFP, a fluorescent probe containing the PIP2-bind-
ing domain from PLCδ fused to GFP. This probe binds to PIP2 
(15) and IP3 (for which the probe has higher affinity; refs. 16, 17). 
As shown in the confocal images in Figure 1A, under basal con-
ditions, the PLCδ-PH-GFP probe localized predominantly to the 
plasma membrane. Application of 200 nM BK produced a strong, 
reversible translocation of the probe to the cytosol (manifested by a 
1.6 ± 0.08–fold rise in cytosolic fluorescence, n = 8; Figure 1A) in 
8 of 14 small neurons (soma diameter, 20–30 μm; typical neurons 
selected for confocal and electrophysiological experiments are 
shown in Supplemental Figure 1A; supplemental material available 
online with this article; doi:10.1172/JCI41084DS1). This result sug-
gests that PLC is activated and PIP2 is hydrolyzed upon BK stimula-
tion in DRG neurons. However, since PLCδ-PH-GFP has a higher 
affinity for IP3 than for PIP2, translocation of the probe does not 
necessarily indicate a significant drop in membrane PIP2 levels, as 
even small amounts of hydrolyzed PIP2 may produce enough IP3 to 
cause the probe to translocate (13, 18). Thus, we used a new PIP2 
probe (YFP-tubby, R332H mutated), which does not bind IP3 (19), 
to probe whether there was a significant depletion of the membrane 
PIP2 pool. Like PLCδ-PH-GFP, the YFP-tubby also localized pre-
dominantly to the plasma membrane (Figure 1B); however, unlike 
PLCδ-PH-GFP, YFP-tubby failed to translocate to the cytosol after 
BK application in 11 of 12 neurons tested (see also Supplemental 
Figure 2). BK, however, induced a robust translocation of the YFP-
Figure 1
Characterization of BK-induced signaling in DRG neurons. (A) BK-induced translocation of the IP3/PIP2 probe PLCδ-PH-GFP, overexpressed 
in DRG neurons. Top panels show confocal micrographs of the transfected neuron before (Control), during (BK), and after (Wash) the applica-
tion of 200 nM BK. Lower panels show the corresponding surface intensity plots. Color scale is absolute pixel intensity (×102). The plot on the 
right shows mean (±SEM) relative increase in cytosolic fluorescence in 8 DRG neurons during BK application (indicated by the bar). (B) As in 
A, but using YFP-tubby probe; n = 11. (C) As in B, but neurons were cotransfected with B2R cDNA (F/F0). Scale bars in A–C: 10 μm. (D and E) 
BK-induced Ca2+ signals in DRG neurons. (D) [Ca2+]i was measured in small DRG neurons loaded with fura-2AM as normalized ratio (R/R0) of 
fluorescence at 340 and 380 nm. BK (200 nM) and CAP (1 μM) were applied during periods indicated by the bars. (E) Experiment similar to that 
shown in D, but Ca2+-free extracellular solution was applied (as indicated by the shaded areas) before and during the BK application.
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tubby in DRG neurons cotransfected with the probe and exogenous 
B2R (Figure 1C), suggesting that this probe is capable of reporting 
BK-induced PIP2 depletion when it is strong enough. These results 
suggest that although BK clearly causes PIP2 hydrolysis and IP3 
generation in DRG neurons (Figure 1A), membrane PIP2 levels do 
not drop to a significant enough degree to induce translocation of 
the YFP-tubby probe, possibly because endogenous PIP2 levels are 
high and/or well buffered in DRG neurons.
We then performed Ca2+ imaging experiments to test whether BK 
application produces Ca2+ signals in DRG neurons. In fura-2AM– 
loaded neurons (preidentified by their response to bath applica-
tion of 30 mM KCl), 200 nM BK induced prominent Ca2+ signals in 
155 of 252 neurons tested (Figure 1D). These signals were usually 
biphasic, with a sharp transient rise followed by a slower and small-
er secondary elevation (Figure 1D). Removal of extracellular Ca2+ 
abolished the secondary responses but not the initial transient one 
(Figure 1E), suggesting that the first, transient phase of the signal 
was predominantly due to Ca2+ release from intracellular stores, 
while the second, slower phase was due to Ca2+ influx pathways 
(see below). In all Ca2+ imaging experiments, we applied the TRPV1 
agonist capsaicin (CAP, 1 μM) at the end to identify TRPV1-posi-
tive nociceptors; 174 of 252 neurons were CAP positive; 107 of 155 
BK-responsive neurons were CAP positive.
BK inhibits M current in small DRG neurons. Previous studies 
revealed that (a) BK induces membrane depolarization in cultured 
small DRG neurons (10–12); and (b) these neurons express several 
M-type K+ channel subunits (Kv7.2, Kv7.3, and Kv7.5; ref. 20), whose 
inhibition induces depolarization and increases AP firing (21, 22). 
Since M channels can be inhibited via PLC pathways (reviewed in ref. 
23), we investigated whether BK affects M current in cultured noci-
ceptive DRG neurons. We identified nociceptors by size and mor-
phology (Supplemental Figure 1A) and by their sensitivity to 1 μM 
CAP. M currents were recorded by amphotericin B–perforated 
patch-clamp using a voltage protocol depicted in Figure 2A (inset) 
and measured as the deactivation tail current amplitude when the 
membrane voltage was stepped from –20 to –60 mV. Bath appli-
cation of BK (10 nM–1 μM) caused a concentration-dependent 
inhibition of M current (Figure 2B) in the majority of the tested 
neurons, with an EC50 of 60.0 ± 16.3 nM. The mean inhibition of 
M current by 200 nM BK amounted to 43.2% ± 4.6% (n = 15) and 
could be partially reversed upon washout (Figure 2A). We used a 
specific M channel blocker, XE991 (3 μM), to verify the identity of 
the deactivation current (Figure 2A and thereafter); XE991 abol-
ished the deactivation tail currents by 96.5% ± 2.1% (n = 56). In a 
representative population of 47 small neurons recorded under the 
same conditions, 28 of 47 were CAP positive, 44 of 47 were BK posi-
tive, and 26 of 28 CAP-positive neurons were BK positive. The larger 
proportion of BK-positive cells seen in the patch-clamp versus Ca2+ 
imaging experiments is likely due to the different selection proce-
dure: small “peanut-shaped” neurons (Supplemental Figure 1A) 
were selected for patch clamp, while imaging was carried out with 
total neurons in the optical field.
Figure 2
BK inhibits M current in DRG neurons. (A) Time course for the effect of 200 nM BK on M current amplitude (Ideac, the amplitude of the deactivating 
tail current at –60 mV; see Methods). A specific M channel blocker, XE991 (3 μM), was applied at the end of the recording. Drugs were applied 
during the periods indicated by the bars. The lower inset shows the current traces recorded at the times indicated by the letters; the dotted line 
indicates a zero current level. The voltage protocol is depicted in the inset above. (B) Concentration dependency of the inhibitory effect of BK on 
M current. The curve represents the fit of data to a logistic equation (see Methods). The n number for each data point is given in parentheses. 
(C–E) As in A, but neurons were pretreated with (C) the specific B2R antagonist Hoe-140 (100 nM), (D) PLC inhibitor edelfosine (10 μM), or (E) 
IP3 receptor blocker xestospongin C (Xe-C, 1 μM). (F) Summary of the pharmacology of BK-induced M current inhibition. Bars show percentage 
M current inhibition by 200 nM BK (Control); BK + 100 nM Hoe-140; BK + 10 μM edelfosine; BK + 1 μM Xe-C; BK + 2 μM thapsigargin (Thap); 
BK + high BAPTA pipette solution; BK + 100 nM bisindolylmaleimide (BIM); and BK + 10 μM quinacrine (Quin). The number of experiments is 
given above each bar; **P ≤ 0.01.
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It has been reported that some BK effects in DRG cultures can be 
mediated by non-neuronal satellite cells (24); thus, we tested wheth-
er the action of BK on M current would also require non-neuronal 
cells. We prepared purified DRG cultures (Supplemental Figure 3 
and Supplemental Methods) and recorded from neurons that were 
not in physical contact with any surrounding cells (Supplemental 
Figure 3B). 200 nM BK still induced inhibition of M current by 
46.0% ± 3.0% (n = 8; versus inhibition under normal culture, 45.1% ± 4.5%, 
n = 14; P > 0.05; Supplemental Figure 3A). Thus, the action of BK 
on M current was due to a primary effect on DRG neurons.
Next we tested the significance of the main steps in the B2R sig-
naling pathway for the BK-induced M current inhibition in DRG 
nociceptors. Pretreatment of neurons with the B2R antagonist 
Hoe-140 (100 nM) and the PLC inhibitor edelfosine (10 μM) abol-
ished M current inhibition (6.3% ± 1.6% and 10.4% ± 1.6% inhibi-
tion of M current, n = 9; Figure 2, C, D, and F). BK-induced M cur-
rent inhibition was also reduced by disruption of intracellular Ca2+ 
signaling: xestospongin C (Xe-C, a membrane-permeable IP3 recep-
tor antagonist), thapsigargin (a sarco-/endoplasmic reticulum 
Ca2+-ATPase inhibitor), and chelation of intracellular Ca2+ with 
the high-affinity Ca2+ buffer BAPTA (20 mM; 12-minute dialysis 
in “fast” whole-cell mode) significantly (P ≤ 0.01) reduced M cur-
rent inhibition (Figure 2, E and F). The PLA2 inhibitor quinacrine 
(10 μM) and the PKC inhibitor bisindolylmaleimide (100 nM) 
were without effect (Figure 2F). In all, the above results suggest 
that BK-induced M current inhibition depends on the PLC- and 
IP3-mediated intracellular Ca2+ rises.
BK activates TMEM16A-dependent Cl– channels. In all our patch-
clamp experiments, BK-induced inhibition of M current was 
always accompanied by the simultaneous activation of an inward 
current at –60 mV (e.g., Figure 2A, inset). The kinetics of devel-
opment of inward current very closely followed that of inhibition 
and recovery of M current (Supplemental Figure 4); the times 
for activation and decay of the inward current were 93 ± 4 sec-
onds and 275 ± 16 seconds (n = 24), respectively, and the times 
for maximal inhibition and recovery of the M current were 95 ± 6 
seconds and 272 ± 18 seconds (n = 24), respectively (Supplemental 
Figure 4). However, inhibition of M current and activation of an 
inward current were indeed distinct phenomena, as robust inward 
currents were still seen when BK was applied in the presence of 
XE991 (Supplemental Figure 5A). We reasoned that this signifi-
cant inward current is likely to have a depolarizing effect on the 
membrane potential of neurons and thus may contribute to the 
excitatory effect of BK. In order to identify this current, we first 
tested TRP channel involvement, since the sensitizing effect of BK 
on different sensory neuron–specific TRP channels (e.g., TRPV1, 
ref. 6; and TRPA1, ref. 7) is well documented. In small DRG neu-
rons voltage-clamped at –60 mV, 200 nM BK evoked inward cur-
rents with an average amplitude of –231.1 ± 27.9 pA (Figure 3, A 
and G, n = 27); 1 μM CAP also induced inward currents of compa-
rable amplitude (–212.7 ± 37.7 pA, n = 22; Figure 3, C and G). The 
effect of CAP was totally abolished by the broad-spectrum Ca2+ 
channel blocker ruthenium red (RR), as the CAP-evoked current 
in the presence of 10 μM RR amounted to only –14.2 ± 1.5 pA 
(n = 12, P ≤ 0.01 compared with CAP alone). In a separate imaging 
experiment, 10 μM RR also completely abolished Ca2+ transients 
induced by the TRPA1 agonist mustard oil (100 μM, Supplemental 
Figure 6). In contrast, RR had no effect on the BK-induced inward 
current (–302.8 ± 41.1 pA in the presence of RR, n = 11; Figure 3, 
B, D, and G). Thus, we concluded that the BK-evoked inward cur-
Figure 3
BK induces Ca2+ activated CaCC in DRG neurons. (A–F) 
Representative current traces showing inward currents 
induced by BK (200 nM) and CAP (1 μM). Traces were 
obtained by continuous recording at a holding potential of 
–60 mV. Dotted lines indicate zero current level. Timing 
of the BK and CAP application is indicated by black bars; 
white bars indicate pretreatment with 10 μM Ca2+ channel 
blocker RR (B and D), 10 μM HCN blocker ZD7288 (E), 
and 100 μM Cl– channel blocker DIDS (F). (G) Summary 
for the pharmacology of the BK-induced inward current 
in DRG. Bars show the peak inward current amplitude 
induced by the following substances: 1 μM CAP; CAP 
+ 10 μM RR; 200 nM BK; BK + 10 μM RR; BK + 10 μM 
ZD7288; BK + 100 nM Hoe-140; BK + 10 μM edelfosine; 
BK + 1 μM Xe-C; BK + 2 μM thapsigargin; BK + high 
BAPTA pipette solution; BK + low [Cl–]i pipette solution; 
BK + 100 μM DIDS. The number of experiments is given 
above each bar in parentheses; **P ≤ 0.01.
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rent was not conducted by RR-sensitive TRP channels. The inward 
current was also not affected by the hyperpolarization-activated 
cyclic nucleotide–gated cation channel (HCN) blocker ZD7288 
(10 μM; –231.2 ± 74.9 pA, n = 5; Figure 3, E and G). However, low-
ering intracellular Cl– ([Cl–]i) by using a K acetate–based pipette 
solution (see Methods) almost completely abolished BK-induced 
inward current (–25.4 ± 4.0 pA, n = 15, P ≤ 0.01 compared with con-
trol). The broad-spectrum chloride channel blocker 4,4ʹ-diisothio-
cyanatostilbene-2, 2ʹ-disulphonic acid (DIDS, 100 μM) also abol-
ished BK-induced inward current (–26.0 ± 4.9 pA, n = 17, P ≤ 0.01 
compared with control; Figure 3, F and G). Other Cl– channel 
blockers, niflumic acid (NFA, 100 μM; Supplemental Figure 5B) 
and 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB, 100 μM; 
data not shown), also effectively blocked BK-induced inward cur-
rents. The above results suggest that the inward current evoked by 
BK was almost exclusively due to chloride channel opening.
CaCCs have been reported in DRG neurons (25–27); therefore, 
we tested whether the BK-induced inward current in DRG neurons 
was mediated by the same B2R/PLC/Ca2+ pathways as the M current 
inhibition. The B2R antagonist Hoe-140 and PLC blocker edelfos-
ine both prevented the inward current responses (–47.9 ± 11.7 pA, 
n = 6 and –45.7 ± 11.4 pA, n = 7; both P ≤ 0.01 compared with con-
trol; Figure 3G). The BK-induced inward current was also signifi-
cantly attenuated by treatment with either Xe-C (–57.5 ± 4.4 pA, 
n = 6, P ≤ 0.01 compared with control; Figure 3G), thapsigargin 
(–26.2 ± 8.1 pA, n = 9, P ≤ 0.01 compared with control; Figure 3G) 
or 20 mM BAPTA in fast whole-cell mode (–19.8 ± 7.5 pA, n = 4, 
P ≤ 0.01 compared with control; Figure 3G), further suggesting 
that this inward current is conducted by CaCCs activated via the 
PLC/IP3/Ca2+ pathway.
In the experiments described above, we varied [Cl–]i in neu-
rons using perforated patch recording with the Cl–-permeable 
pore-forming agent amphotericin B. In order to evaluate the 
endogenous electrochemical driving force for Cl–, we used gram-
icidin in the patch pipette, which forms Cl–-impermeable pores 
(28). First we confirmed that in gramicidin-perforated patch 
BK still induces inward currents at –60 mV (–65.3 ± 11.1 pA, 
n = 8; Figure 4, A and B); the BK-induced inward current recorded 
in gramicidin-perforated patch in combination with “low [Cl–]i” 
pipette solution was smaller compared with that recorded with 
amphotericin B with “high [Cl–]i” pipette solution (Figure 4B) 
but still substantial. Accordingly, the low [Cl–]i pipette solution 
abolished BK-induced inward current when recordings were 
made with amphotericin B but not with gramicidin (Figure 4B). 
These data suggest that [Cl–]i in DRG neurons is high enough 
to maintain a driving force for inward current at –60 mV. To 
determine the endogenous reversal potential for Cl– currents 
in small DRG neurons, we studied GABA-induced currents in 
gramicidin-perforated patch. In these experiments, NaCl in the 
extracellular solution and KCl in the pipette solution were sub-
stituted with equimolar tetraethylammonium chloride (TEA-Cl) 
and CsCl, respectively. In accordance with previously published 
data (29), 200 μM GABA induced Cl– currents that reversed at 
–37.4 ± 2.7 mV; importantly, BK-induced currents reversed at 
the same potentials (–34.2 ± 4.3 mV; Figure 4, C and D), further 
supporting our assumption that BK-induced inward currents in 
small DRG neurons are in fact Cl– currents.
The gene encoding an essential CaCC subunit (Tmem16a) has 
recently been identified (30–32). Thus, we used siRNA against 
Tmem16a to test whether it is a molecular correlate of the 
BK-induced Cl– current in small DRG neurons. Transfection (using 
a Nucleofector device, Amaxa) of siRNA significantly reduced lev-
els of Tmem16a mRNA (Figure 5F; Supplemental Figure 7, C and 
D) and protein (Figure 5G and Supplemental Figure 7, A and B), 
as compared with the levels in acutely dissociated cells and cul-
tures from P7 and adult rats and also as compared with the cul-
tures transfected with the scrambled oligo control. A TMEM16A 
antibody stained neurons coexpressing TRPV1 and the M channel 
subunit Kv7.2 but not satellite glial cells (Supplemental Figure 1B 
and Supplemental Figure 7A). In cells transfected with Tmem16a 
siRNA, TMEM16A but not TRPV1 immunoreactivity was reduced 
(Supplemental Figure 7A). Tmem16a siRNA did not affect expres-
sion of Tmem16b, which was also expressed in DRG but at a much 
lower level than Tmem16a (Supplemental Figure 7, C and D).
Figure 4
Characterization of BK-induced inward currents using gram-
icidin-perforated patch. (A) Representative current trace 
showing BK-induced (200 nM) inward current in gramicidin-
perforated patch using low [Cl–]i pipette solution. (B) Summa-
ry statistics for the BK-induced inward currents recorded with 
amphotericin B (high [Cl–]i and low [Cl–]i pipette solutions) 
and gramicidin (low [Cl–]i pipette solution). **P ≤ 0.01 com-
pared with low [Cl–]i amphotericin B. (C) Representative cur-
rent traces induced in small DRG neuron by the voltage ramp 
from –80 mV to +40 mV (depicted above the traces) applied 
on the peak of BK- (200 nM) or GABA-induced (200 μM) 
currents. (D) Mean reversal potentials for BK- and GABA-
induced currents recorded as in C. The number of experi-
ments is given below each bar.
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In small DRG neurons transfected with 2 different scrambled 
oligos, BK induced a robust inward current with a mean amplitude 
of –90.5 ± 18.6 pA (scrambled 1, n = 10; Figure 6, A and B) and of 
–115.6 ± 22.5 pA (scrambled 2, n = 5; Figure 6B); the amplitude of the 
BK-induced inward current in mock-transfected neurons (cells were 
electroporated but without any RNA) was –103.4 ± 27.6 pA (n = 5; 
Figure 5B). In contrast, neurons transfected with Tmem16a siRNA 
responded to BK with much smaller currents (–43.8 ± 15.0 pA, 
or 48% of the value for the scrambled 1 oligo control, n = 12, 
P < 0.05; Figure 5, A and B). The inward current amplitudes in all 
variants of transfected controls were smaller than that recorded 
in nontransfected cells (Figure 3), suggesting some nonspecific 
Figure 5
CaCC current in DRG neurons depends on expression of TMEM16A. (A) Current at –60 mV induced by BK (200 nM) in small DRG neurons is attenu-
ated by Tmem16a siRNA (right trace) but not by the scrambled siRNA control (left trace). (B) Mean peak inward current amplitudes for experiments as 
in A, for cells transfected with 2 different scrambled oligos (scrambled 1 and 2), mock-transfected cells, and cells transfected with Tmem16a siRNA. 
*P ≤ 0.05; numbers of experiments are shown in the bars. (C–E) Tmem16a siRNA does not affect BK-induced inhibition of M current. Application 
of 200 nM BK to the neuron transfected with Tmem16a siRNA induced robust inhibition of M current, which was recorded by the voltage pulse from 
–30 mV to –60 mV (inset above the current traces in D). (E) Mean M current inhibition by BK in neurons transfected with scrambled oligos or Tmem16a 
siRNA. (F) Tmem16a mRNA levels (normalized to the housekeeping gene U6) in DRG cultures transfected with scrambled oligo (scrambled 1) or 
Tmem16a siRNA, as well as in untransfected culture and acutely dissociated DRG prep from an adult (8 weeks) rat; **P ≤ 0.01. (G) Western blot show-
ing decrease in TMEM16A protein abundance (band at 116 kDa) in whole cell lysates of DRG cells transfected with Tmem16a siRNA (as compared 
with the scrambled oligo control 1) and whole protein lysate from acutely extracted DRG (no cell culture) of P7 rat; loading control was β-actin.
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effects of electroporation; nevertheless, the effect of the siRNA was 
specific. Furthermore, in neurons with Tmem16a knockdown, BK 
still induced robust inhibition of M current (Figure 5, C–E).
Our data strongly suggest that the BK-induced inward current in 
small DRG neurons is CaCC; however, BK was also shown to sen-
sitize several sensory TRP channels such as TRPV1 (6) and TRPA1 
(7) that, when open, conduct inward cationic currents at negative 
voltages. Particularly, sensitization of TRPV1 by BK results in a 
leftward shift of the temperature response curve such that the 
threshold for channel activation shifts closer toward body temper-
ature (33). We thus performed further patch-clamp and imaging 
experiments to test the involvement of TRP channels in the acute 
effects of BK on DRG nociceptors at 37°C. In the majority (13 of 
20) of small CAP-positive neurons, BK-induced inward currents 
were not seen when recorded in amphotericin B–perforated patch 
mode in combination with low [Cl–]i pipette solution (Figure 6, A 
and D). In only 7 of 20 CAP-positive neurons, BK induced small 
non-Cl– inward currents of –48.9 ± 7.5 pA (Figure 6, B and D); these 
currents were much smaller than those recorded with high [Cl–]i 
pipette solution (–190.2 ± 69.9 pA, 4 of 4 neurons; Figure 6, C and 
D). We also tested the effect of BK on DRG neurons overexpressing 
exogenous B2Rs. Even with B2R overexpression, application of BK 
induced only very small inward currents of –11.24 ± 2.23 pA (n = 8; 
recordings were made with low [Cl–]i pipette solution in the pres-
ence of 3 μM XE991 at room temperature). As a control for these 
sets of experiments, we tested whether we could detect BK-induced 
sensitization of TRPV1 to CAP, and indeed we found that when 2 
successive applications of 50 nM CAP were separated by 5 minutes 
of treatment with 200 nM BK, in 6 of 9 CAP-positive neurons, the 
second CAP application produced 1.7 ± 0.2–fold larger current 
than the first CAP application (data not shown). Together, these 
findings suggest that coupling of endogenous B2R to sensory TRP 
channels in small DRG neurons is such that it provides for sensiti-
zation but less so for activation of these channels.
We also performed detailed characterization of the BK-induced 
Ca2+ rises at 37°C in imaging experiments (Figure 6, E–G). In 
order to quantify the contribution of a second-phase response 
to the total BK-induced Ca2+ signal, we calculated the total area 
under the curve of the ratiometric Ca2+ signal and divided it by 
the peak amplitude of Ca2+ signal (see Figure 6F, inset, and Meth-
ods); the larger the contribution of the second-phase Ca2+ rise to 
the total Ca2+ signal, the higher the value of this area/peak param-
eter. The dotted line in Figure 6F indicates the predicted value for 
the area/peak parameter for a single Gaussian peak of amplitude 
(R/R0 = 2.25) and time to peak (15 seconds), characteristic of the 
mean (n = 34) BK-induced Ca2+ transient in small CAP-positive 
DRG neurons (i.e., the value for the mean BK-induced Ca2+ peak 
with no second phase).
Figure 6
Characterization of BK-induced inward currents and 
Ca2+ transients at 37°C. (A–C) Representative current 
traces showing inward currents at 37°C induced by 
200 nM BK and 1 μM CAP. (A) In 13 of 20 CAP-posi-
tive neurons, BK did not induce inward current during 
recording with low [Cl–]i pipette solution. (B) In 7 of 20 
neurons, BK induced small inward currents (low [Cl–]i 
pipette solution). (C) In 4 of 4 CAP-positive neurons, 
BK induced large inward currents during recording with 
high [Cl–]i solution. (D) Summary for experiments in 
A–C. (E) Exemplary Ca2+ imaging experiments (simi-
lar to that in Figure 1, D and E) at 37°C. BK (1 μM) 
was applied either alone (Control) or after 5 minutes 
preincubation with (and in the presence of) 10 μM cap-
sazepine (CZP) or a VGCC-blocking cocktail (1 μM 
ω-conotoxin GVIA, 100 nM agatoxin TK, 1 μM nifedip-
ine, 50 μM NNC 55-0396). (F) Pharmacological char-
acterization of the second-phase Ca2+ rises induced 
by BK. The y axis is the relative area/peak parameter 
and is a measure of the second-phase Ca2+ rise (see 
Methods and explanation in Results). Bars represent 
mean area/peak parameter for Ca2+ transients induced 
by BK only (Control) or by BK in the presence of 10 μM 
RR, 10 μM CZP, VGCC-blocking cocktail, 1 mM NiCl2 
(Ni2+), 100 μM NFA or VGSC blockers (1 μM TTX and 
100 nM A-803467). (G) Bars represent mean normal-
ized peak of ratiometric BK-induced Ca2+ signal (R/R0); 
all labeling as in F. Only CAP- and BK-positive neu-
rons were included in E and F. The number of cells is 
given in parentheses. **P ≤ 0.01.
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RR had no effect on either the peak Ca2+ rise or area/peak param-
eter (Figure 6, F and G), while the more specific TRPV1 blocker 
capsazepine (10 μM) had a small but significant effect on the 
second-phase Ca2+ rise (but not on the peak rise; Figure 6, E–G). 
In contrast, the nonspecific voltage-gated Ca2+ channel (VGCC) 
blocker Ni2+, as well as a cocktail of specific N-, P/Q-, T-, and 
L-type Ca2+ channel blockers and toxins (see Methods), significant-
ly reduced both the peak and the second phase of the BK-induced 
Ca2+ rise (with a proportionally greater effect on the second phase; 
Figure 6, E–G). NFA (100 μM) also substantially reduced the sec-
ond-phase and peak Ca2+ rises, suggesting that Cl– channel–medi-
ated depolarization may contribute to these rises. These results 
suggest that VGCCs significantly contribute to the BK-induced 
Ca2+ rises, particularly to the second phase. We also tested whether 
AP firing is necessary for VGCC activation during the second phase 
of the Ca2+ response by treating neurons with a combination of 
tetrodotoxin (TTX, 1 μM) and A-803467 (100 nM) to block TTX-
sensitive and -insensitive voltage-gated sodium channels (VGSCs) 
(34). This combination of VGSC inhibitors effectively blocked AP 
firing in small DRG neurons (data not shown); however, it did 
not significantly affect either the peak or the second phase of the 
Ca2+ signals (Figure 6G). Taken together, the results of Figure 1, 
D and E, and of Figure 6 suggest that the BK-induced Ca2+ sig-
nal is complex in nature and that the primary event is the release 
of Ca2+ from intracellular stores, which triggers a secondary Ca2+ 
influx, mainly through VGCCs that are activated by depolariza-
tion caused by the primary Ca2+ release. AP firing does not seem 
to be necessary for this VGCC activation. The contribution of TRP 
channels to acute BK-induced Ca2+ signals is small even at 37°C; 
however, the involvement of other RR-insensitive cationic chan-
nels cannot be excluded.
Since VGCCs in small DRG neurons are activated during the 
second phase of BK-induced Ca2+ signals, we tested whether Ca2+ 
influx through VGCCs can in turn activate CaCCs. Andre and 
colleagues have reported that in medium and large mouse DRG 
neurons, CaCCs indeed can be activated by VGCC-mediated Ca2+ 
influx; however, in small neurons, VGCC-coupled CaCC current 
was not found (26). In our study (and also in ref. 35), CaCC cur-
rent in CAP-positive nociceptors was activated by BK-induced 
Ca2+ transients; we thus asked whether this CaCC current can also 
be activated by VGCC-mediated Ca2+ influx. We performed fast 
whole-cell recordings using solutions and voltage protocols as in 
ref. 26. Consistent with the previous study, we found that in the 
majority (34 of 44) of small CAP-positive neurons, VGCC activa-
tion did not result in CaCC activation (Supplemental Figure 8A). 
In only 10 of 44 neurons, variable inward “tail” currents developed 
after the VGCC-activating pre-pulse (Supplemental Figure 8, B 
and C); these tail currents were sensitive to 100 μM NFA (data 
not shown). We concluded that in most small DRG neurons (in 
contrast to the medium/large ones), the coupling between VGCC 
and CaCC is minimal, which may suggest either poor spatial colo-
calization of CaCCs and VGCCs or a different molecular identity 
of CaCCs in small compared with large DRG neurons. Of note is 
also the fact that our voltage protocol for measuring M current 
involves repetitive stepping from –20 to –60 mV, a protocol that is 
likely to activate VGCCs; however, in perforated patch recordings 
M currents usually do not exhibit noticeable rundown, suggesting 
that Ca2+ influx through VGCCs in DRG neurons is not capable of 
producing noticeable inhibition of M channels either.
All experiments on M current inhibition and CaCC activation 
described above were performed on cultured neurons from P7 rats. 
Could we apply our findings to native neurons from adult animals? 
Robust M currents were reported in DRG neurons from P17 (20) 
and from 6-week-old adult rats (21); moreover, we recently reported 
that M current can be recorded from acute DRG slices, and this 
current can be inhibited by the activation of PLC (22). However, no 
such data exist for TMEM16A/CaCC (although strong TMEM16A 
immunoreactivity in small DRG neurons of adult mice has been 
Figure 7
M channel inhibition and CaCC activation account 
for the BK-induced excitability in small DRG neurons. 
Current clamp recordings from small DRG neurons; 
APs were elicited by 200 pA current injection for 
a 500-ms period. (A) Under symmetrical Cl– con-
ditions (high [Cl–]i pipette solution), XE991 (3 μM) 
increased the number of APs elicited by the depo-
larizing current injection; subsequent application of 
200 nM BK (together with XE991) further increased 
firing frequency; n = 5. (B) Experiment similar to A, 
but performed with low [Cl–]i pipette solution. Under 
such conditions, application of BK does not cause 
any additional increase in XE991-induced AP firing; 
n = 6. (C) Another experiment with low [Cl–]i pipette 
solution; this time, BK was applied first. In this case, 
BK was able to produce some excitation; subse-
quent application of XE991 (in the presence of BK) 
produced an additional increase in firing; n = 4. Bar 
charts at the bottom summarize the effects shown 
above; *P ≤ 0.05, **P ≤ 0.01.
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reported; ref. 32). Thus, we tested whether BK-induced inward cur-
rent can be recorded in acutely dissociated DRG neurons from adult 
rats. Consistent with the data shown in Figure 3, BK induced robust 
Cl–-selective inward currents in small DRG neurons from 8-week-old 
adult rats just 4 hours after dissociation (Supplemental Figure 5B). 
In addition, the levels of Tmem16a transcript were similar in DRG 
cultures and acutely dissociated DRGs from adult rats (Figure 5F).
M current inhibition and CaCC activation contribute to and can account 
for the excitatory effect of BK. We examined how the effects of BK on M 
channels and CaCCs affect the excitability of small DRG neurons. 
In control neurons under current-clamp conditions (amphoteri-
cin B–perforated patch recording with regular, high [Cl–]i pipette 
solution), injection of 200 pA depolarizing current usually elic-
ited only 1 or 2 APs (Figure 7A and Supplemental Figure 9, A and 
B). AP firing frequency was remarkably increased by 200 nM BK 
from 2.0 ± 0.6 AP/500 ms to 6.6 ± 1.3 AP/500 ms (n = 7, P ≤ 0.01; 
Supplemental Figure 9A). BK also substantially depolarized 
the membrane potential from –56.8 ± 2.3 mV to –44.0 ± 3.0 mV 
(n = 9, P ≤ 0.01; Supplemental Figure 9C). The specific M channel 
blocker XE991 (3 μM) also significantly increased the AP firing 
frequency from 1.4 ± 0.3 AP/500 ms to 4.1 ± 0.7 AP/500 ms (n = 11, 
P ≤ 0.01; Supplemental Figure 9B) and induced depolarization from 
–55.7 ± 2.4 mV to –42.7 ± 2.5 mV (n = 15, P ≤ 0.01; Supplemental 
Figure 9D). However, the number of APs elicited by the application 
of XE991 was smaller than that induced by BK (Supplemental Fig-
ure 9, A–C) or when BK and XE991 were coapplied after the first 
application of XE991 only (3.0 ± 0.4 AP/500 ms in the presence 
of XE991 only versus 8.8 ± 2.0 AP/500 ms in the presence of BK 
plus XE991, n = 5, P ≤ 0.05; Figure 7A). These data suggest that 
both BK and XE991 can depolarize DRG neurons and increase AP 
firing frequency; however, under symmetrical Cl– conditions, the 
effect of BK is stronger and contains a component that cannot be 
accounted for by the inhibition of M channels.
To test whether CaCC activation contributes to the excitatory 
effect of BK, we used a low [Cl–]i pipette solution, which abolished 
the BK-induced inward current. Under such conditions, the ability of 
XE991 (3 μM) to increase AP firing was unchanged (an increase from 
1.4 ± 0.4 AP/500 ms to 5.0 ± 1.0 AP/500 ms, n = 6, P ≤ 0.05; Figure 7B), 
while subsequent coapplication of BK plus XE991 failed to pro-
duce further excitation (4.6 ± 1.1 AP/500 ms, n = 6; Figure 7B). 
Moreover, at low [Cl–]i, BK (which inhibits some 50% of M current), 
when applied alone, was less potent in increasing AP firing than BK 
plus XE991 (with XE991 inhibiting M current almost completely; 
2.8 ± 0.3 AP/500 ms in the presence of BK only versus 4.8 ± 0.8 AP/ 
500 ms in the presence of BK plus XE991, n = 4, P ≤ 0.05; Figure 7C). 
Taken together, these experiments demonstrate that both M cur-
rent inhibition and CaCC activation contribute to the acute excit-
atory action of BK on sensory neurons; moreover, the combination 
of both effects can satisfactorily account for such action.
M channel openers and CaCC blockers can reduce nocifensive behavior 
induced by BK. We next tested whether pharmacological targeting 
of M channels and CaCC can influence BK-induced nocifensive 
behavior in rats. We evaluated nocifensive behavior (time spent 
licking, biting, and flinching the affected paw) after hind paw 
injection of 50 μl of saline containing the relevant compounds. 
Consistent with previous literature (2), intraplantar injection of 
BK (10 nmol/site) into the rat hind paw produced strong nocifen-
sive behavior (quantified within the first 30 minutes after injec-
tion), which was not observed in rats injected with saline (Fig-
ure 8A). In order to investigate whether M channel inhibition or 
CaCC activation contributes to BK-induced nocifensive behavior, 
we preinjected the M channel opener retigabine or different CaCC 
blockers into the same plantar region of the hind paw where 5 
minutes later BK was injected. This protocol limits central effects 
of the drugs and ensures that the preinjected drugs act on the 
same sensory neuron terminals as BK. We first tested whether the 
M channel opener retigabine can reduce BK-induced nocifensive 
behavior. We reasoned that M channels inhibited by BK might 
be “rescued” with retigabine. Retigabine (5 nmol/site) indeed 
Figure 8
M channel openers and CaCC blockers attenuate BK-induced nocifensive 
behavior. (A) Cl– channel blockers NPPB (10 nmol/site), NFA (50 nmol/site), 
DIDS (50 nmol/site), or M channel opener retigabine (RTG, 5 nmol/site) 
or vehicles (DMSO, Veh1; NaHCO3, Veh2) were dissolved in saline 
and injected into the rat hind paw 5 minutes before the injection of BK 
(10 nmol/site) or saline in 50 μl (second injection was done into the 
same site). Nocifensive behavior was quantified as the time spent lick-
ing, biting, and flinching during 30 minutes. n = 7 for each group. (B) 
RR attenuated CAP- but not BK-induced nocifensive behavior. RR (50 
nmol/site) or vehicle were preinjected 5 minutes prior to CAP or BK 
injection; n = 8 for each group. (C) Injection of M channel blocker XE991 
(30 nmol/site) induced nocifensive behavior and attenuated BK-induced 
nociception. XE991 or vehicle control were injected into the plantar sur-
face of the right hind paw either on their own or as pretreatment prior to 
BK injection; n = 7 for each group. *P ≤ 0.05; **P ≤ 0.01.
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significantly attenuated BK-induced pain responses (Figure 8A). 
Accordingly, in patch-clamp experiments, application of retiga-
bine effectively reversed the inhibitory effect of BK on M current 
at –60 mV (Supplemental Figure 5E).
We then tested whether pharmacological inhibition of CaCC 
would also have an anti-nocifensive effect. Preinjection of the Cl– 
channel blockers DIDS (50 nmol/site) and NPPB (10 nmol/site) 
indeed significantly attenuated the BK-induced nocifensive behav-
ior; NFA (50 nmol/site) also had a tendency to reduce the effect of 
BK (Figure 8A). We also tested the potential antinociceptive effect 
of RR. Intraplantar preinjection of RR (50 nmol/site) had no effect 
on BK-induced nociception (Figure 8B); however, as expected, RR 
did attenuate the nocifensive behavior produced by intraplantar 
injection of CAP (3 μg/site). Finally, we tested the nociceptive 
effect of peripheral M channel inhibition. In accordance with our 
previous study (22), intraplantar injections of XE991 (30 nmol/
site) alone induced moderate nocifensive behavior (Figure 8C). 
Coinjection of XE991 with BK did not result in additional noci-
fensive responses; rather, there appeared to be a reduction in the 
pain response, which possibly may have resulted from desensitiza-
tion of peripheral terminals caused by XE991-mediated sustained 
depolarization. These data suggest that M channel inhibition does 
not add any additional component to BK-induced nociception.
Discussion
M channels and BK-induced excitability in sensory neurons. M channels 
(Kv7 or KCNQ) conduct slow-kinetic, non-inactivating K+ currents 
with a threshold for activation below –60 mV, allowing a fraction 
of M channels to remain open at or near the resting membrane 
potential of a neuron. It is therefore suggested that neuronal M 
current serves as an intrinsic “voltage clamp” mechanism that 
controls the resting membrane potential, threshold for AP fir-
ing, and accommodation within AP trains (23). Accordingly, M 
channel inhibition depolarizes neurons, making them more excit-
able, while M current augmentation has the opposite effect (20, 
36–38). Growing evidence suggests that functional M channels are 
expressed in peripheral sensory fibers and their activity strongly 
contributes to fiber excitability in vivo (22, 39–42). Here we show 
that BK inhibits M current in nociceptors, that M current inhibi-
tion is excitatory and causes nociception, and that the nociceptive 
effect of BK could be attenuated by the pre-application of a spe-
cific M channel opener (Figure 8).
Gq/11-coupled receptors can inhibit M currents via PLC-induced 
PIP2 depletion (as M channels require PIP2 for their activity; refs. 
43–45), IP3-mediated Ca2+ rises (as M channels are inhibited by 
Ca2+/calmodulin; refs. 46, 47), or a combination of both (48). Our 
data suggest that in DRG neurons, the Ca2+-mediated pathway 
prevails. Indeed, pharmacological inhibition of Ca2+ release from 
IP3-sensitive stores or chelating intracellular Ca2+ with BAPTA 
(Figure 2) were almost as effective in preventing BK-induced M 
current inhibition as direct PLC inhibition. Imaging experiments 
(Figure 1) also suggest that despite activation of PLC by B2R, the 
overall membrane PIP2 level in most DRG neurons may not change 
dramatically, since YFP-tubby (PIP2 reporter that does not bind 
IP3; ref. 19) did not translocate in response to BK application (until 
B2Rs were overexpressed).
New role of CaCCs in nociceptors. CaCCs are a prominent group of 
ion channels robustly expressed in many mammalian cell types, 
including neurons, smooth muscle and epithelial cells (49). In the 
nervous system, functional CaCCs are best characterized in neurons 
mediating different sensory inputs, such as olfactory neurons (50, 
51) or photosensitive rods and cones (52, 53), where these channels 
amplify excitatory inputs (e.g., the response to odorants mediated 
by Ca2+ influx through opening of CNG channels; ref. 54).
A critical prerequisite for Cl– channels to conduct a depolar-
izing inward current is an equilibrium potential for Cl– (ECl) that 
is more positive than the resting membrane potential of a neu-
ron (–80 to –55 mV). In an archetypal CNS neuron, [Cl–]i is low 
and ECl is more negative than the resting membrane potential, so 
the activation of Cl– channels (e.g., GABA) has a hyperpolarizing 
(inhibitory) effect. This, however, may not hold true for many 
types of sensory neurons, and there is evidence that there is a 
higher tonic [Cl–]i in peripheral sensory neurons, leading to ECl 
values in the range of –50 to –10 mV (refs. 55, 56 and the present 
study), which is well above the resting membrane potential. In 
our experiments on small nociceptive DRG neurons, both GABA 
and CaCC currents reversed at –35 mV to –40 mV (Figure 4). A 
recent report suggests that even further [Cl–]i accumulation in 
DRG neurons occurs in response to inflammation (55). In cur-
rent clamp experiments (Figure 7 and Supplemental Figure 9), 
we clearly observed that under high [Cl–]i conditions, CaCC acti-
vation can amplify the excitatory effect of BK. Accordingly, intra-
plantar preinjection of CaCC blockers attenuated BK-induced 
nocifensive behavior in rats (Figure 8).
The molecular identity of CaCC remained controversial until 
very recently, when 3 groups independently identified a member of 
the transmembrane protein 16 (TMEM16 or anoctamin) protein 
family as a CaCC subunit (30–32). Most recently, another member 
of this family, TMEM16B was also shown to have CaCC activity 
(57). We still know little about the structural basis for the Cl– con-
ductance and Ca2+ sensitivity of TMEM16A, but its identification 
as a molecular correlate of CaCC makes it possible to alter CaCCs 
in native cells via genetic manipulation. In this study, we detected 
TMEM16A immunoreactivity in TRPV1-positive DRG neurons 
(Supplemental Figures 1 and 7) and used the siRNA approach to 
show that Tmem16a knockdown reduces CaCC currents in these 
cells (Figure 5). We also detected Tmem16b expression in total DRG 
culture extracts, but its level of expression was approximately 100 
times lower than that of Tmem16a.
An apparently different type of endogenous CaCC current has 
been reported in medium/large DRG neurons. This CaCC current 
was reported to couple to VGCC activation (26), while in the case 
of CaCC in small DRG neurons, such coupling is weak (the pres-
ent study). Such a lack of coupling between CaCC and VGCC in 
nociceptors may be required in order to avoid a self-maintaining 
positive feedback loop, since if Ca2+ influx through VGCC would 
significantly activate CaCC (and inhibit M channels), this would 
then cause depolarization and Ca2+ influx through VGCC and fur-
ther amplification of the cycle. Interestingly, Tmem16a is highly 
expressed in the majority of small DRG neurons but not in large 
neurons (32); moreover, it was recently suggested that Best1 under-
lies CaCC in large neurons (58). Taken together, these two observa-
tions may indicate that CaCC in different types of neurons consist 
of distinct molecular components.
Contribution of other currents to the acute effect of BK. In our experi-
ments, the inhibition of M current and activation of CaCC were 
the most prominent effects of BK on ionic currents in DRG 
neurons; moreover, these effects satisfactorily accounted for the 
observed excitatory action of BK. Our data suggest that the con-
tribution of TRP channels to the acute effects of BK in nociceptors 
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is not large, as the non-Cl– component of the BK-induced inward 
currents was small even at 37°C (Figure 6); overexpression of 
B2Rs in DRG neurons also did not result in large non-Cl– BK-acti-
vated currents; finally, TRP channel blockers had little effect on 
BK-induced Ca2+ transients (Figure 6) or nociceptive behavior (Fig-
ure 8). Our results seem at odds with publications suggesting that 
BK can activate TRPV1 (59, 60) and TRPA1 (61). Nevertheless we 
confirmed the sensitizing effect of BK on TRPV1 via endogenous 
B2Rs; moreover, small non-Cl– inward currents in response to BK 
recorded at 37°C suggest that some degree of sensory TRP chan-
nel activation by BK may happen in vivo. We believe that in our 
experimental conditions, B2R indeed produced some sensitization 
of sensory TRP channels, but the overall contribution of this effect 
to the acute BK-induced excitability and nociception was small. A 
recent report suggested that acute BK-induced nocifensive behav-
ior in Trpv1-knockout mice was affected only marginally (62). The 
study tested two doses of BK, 0.1 and 1 nmol/site; the behavioral 
responses to BK did not differ between wild-type and Trpv1–/– ani-
mals at a higher BK dose, and at a lower dose the percentage of 
BK-responsive animals was smaller in the Trpv1–/– group, but the 
amount of distress experienced by the responsive animals did not 
change significantly. Moreover, BK-induced excitation of cutane-
ous C fibers was similar in wild-type and Trpv1–/– mice at a range of 
BK concentrations. Thus, we suggest that B2R-TRP coupling may 
have a stronger role in the BK-induced hyperalgesia/allodynia than 
in the acute nociception produced by BK.
General principles of spontaneous inflammatory nociception. Inflam-
matory mediators (such as BK, proteases, histamine, prosta-
glandins, IL1-β, ATP, NGF, etc.) often act via G protein–coupled 
receptors or ligand-gated ion channels to acutely depolarize the 
plasma membrane of sensory fibers, reduce the threshold for 
AP firing, and increase firing frequency (3). Our data as well as 
emerging work from many other research groups allow us to pro-
pose certain common principles underlying the “spontaneous” 
excitation of peripheral sensory neurons in inflammation: (a) 
weakening of intrinsic “voltage clamp” — e.g., through M chan-
nel inhibition (ref. 22 and the present study); (b) depolarizing 
input — e.g., through activation of cationic channels such as P2X 
(63) and TRP (61, 64) or anionic channels such as CaCCs (the 
present study); (c) amplification of the depolarizing input — e.g., 
by the upregulation of VGSCs (65, 66) or by positive feedback 
activation of CaCCs.
Methods
The use of animals in this study was approved by the University of Leeds 
Ethical Review Committee and by the Animal Care and Ethical Committee 
of Hebei Medical University.
Rat DRG cell culture. DRGs were extracted from all spinal levels of 7-day-
old Wistar rats, and neurons were dissociated and cultured as described 
previously (22, 67). For preparation of purified DRG culture, see Supple-
mental Methods.
Electrophysiology. Unless stated otherwise, recordings were made at room 
temperature. Patch electrodes were pulled from borosilicate glass and fire-
polished to a final resistance of 2–4 MΩ when filled with internal solution. 
An EPC-10 patch clamp amplifier in combination with Patchmaster version 
2.2 software (HEKA) was used for voltage and current clamp experiments. 
Most recordings were done using either amphotericin B– (250 μg/ml; 
Sigma-Aldrich) or gramicidin-perforated (100 μg/ml; Sigma-Aldrich) 
patch technique. Regular (high [Cl–]i) internal pipette solution contained 
(in mM): 150 KCl, 5 MgCl2, 10 HEPES, pH 7.4. In the low [Cl–]i pipette 
solution, KCl was replaced by equimolar K-acetate. Calcium clamping 
experiments were done using fast whole-cell recording using the follow-
ing “high BAPTA” internal solution (in mM): 115 KCl, 5 MgCl2, 5 HEPES, 
20 BAPTA, 3 K2ATP, 0.1 NaGTP, and 10 CaCl2, pH 7.4. The external solu-
tion contained (in mM) 160 NaCl, 2.5 KCl, 5 CaCl2, 1 MgCl2, 10 HEPES, 
and 8 glucose, pH 7.4. A low-profile perfusion chamber fed by a gravity 
perfusion system was used for solution exchange (2 ml/min, bath exchange 
time of ~15 seconds). M current amplitude was measured from the deac-
tivation current elicited by a 500-ms square voltage pulse to –60 mV from 
a holding potential of –20 mV or –30 mV, calculated as the difference 
between the average of a 10-ms segment, taken 20–30 ms into the hyperpo-
larizing step, and the average during the last 50 ms of that step. Additional 
details are provided in Supplemental Methods.
Fluorescence imaging. Ca2+ imaging was performed as described previously 
(46); briefly, neurons were loaded with fura-2AM (2 μM) in the presence 
of Pluronic F-127 (0.02%) and imaged using a Nikon TE-2000 microscope 
(10× objective) equipped with a T.I.L.L. Photonics Ca2+ imaging system 
(Polychrome V monochromator and IMAGO CCD camera). Cells were 
excited alternatively at 340 and 380 nm and images analyzed with TILLvi-
sION 4.5.56. Only neurons responding with a greater than 10% rise (peak) 
in F340/F380 were counted as BK positive. The area/peak parameter in 
Figure 6F was calculated according to the following equation:
                                                                                                      (Equation 1)
where a and b are the start and end points of the Ca2+ transient (Figure 6F, 
inset).
Translocation of PIP2 probes was recorded using a LiveScan Swept Field 
Confocal System (Nikon) as in ref. 22, and data were analyzed using NIS 
Elements imaging software (Nikon).
DNA constructs, siRNA, and transfections. Freshly isolated DRG neurons 
were transfected with PLCδ-PH-GFP (gift from Tobias Meyer, Stanford 
University, California) or YFP-tubby (tubby-R332H-cYFP; gift from 
Andrew Tinker, UCL, London, United Kingdom) with or without B2R (gift 
from Mark Shapiro, UT Health Science Center San Antonio, Texas) using 
a Nucleofector device (Amaxa) and used 3–5 days after transfection. siRNA 
oligonucleotide sequences against Tmem16a (with matching scrambled 
controls) were designed using BLOCK-iT RNAi designer (Invitrogen): 
siRNA sense, CCUGGUCAGGAAAUACUUU[dT][dT], antisense, AAAG
UAUUUCCUGACCAGG[dT][dT]; scrambled 1 sense, CCUACUAGGUAA
CAGGUUU[dT][dT], antisense, AAACCUGUUACCUAGUAGG[dT][dT]; 
scrambled 2 sense, GCAGUAUUCCGAUAGACUU[dT][dT], antisense, 
AAGUCUAUCGGAAUACUGC[dT][dT]. Amaxa’s Nucleofector device 
was used for siRNA delivery; the efficiency of Tmem16a knockdown was 
checked by quantitative RT-PCR (Bio-Rad), immunocytochemistry, and 
Western blot analysis (see Supplemental Methods). In patch-clamp experi-
ments, RNA oligos were cotransfected with EGFP cDNA, and neurons with 
green fluorescence were analyzed.
Behavioral studies. Sprague-Dawley rats (body weight, 190–240 g) were ran-
domly grouped and allowed to acclimatize for at least 20 minutes in a trans-
parent observation chamber before the experiment. The right hind paw of 
the animal received an intraplantar injection (50 μl) of BK (10 nmol/site) 
or vehicle, and the nocifensive responses (licking, biting, lifting, and flinch-
ing) were recorded using a video camera for 30 minutes. The videos were 
analyzed by an observer unaware of treatment allocations. In the experi-
ments with M channel openers and CaCC or TRP blockers, these drugs 
were preinjected in the same plantar of the hind paw where 5 minutes later 
BK was injected. Drugs were dissolved in saline (pH 7.4) from stock solu-
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tions and applied in a volume of 50 μl at the following doses: retigabine, 
5 nmol/site; DIDS, 50 nmol/site; NPPB, 10 nmol/site; NFA, 50 nmol/site; 
CAP, 3 μg/site; RR, 50 nmol/site; XE991, 30 nmol/site.
Statistics. The concentration-response curve was fitted with logistic equa-
tion: y = A2 + (A1 – A2)/[1 + (x/x0)p], where y is the response; A1 and A2 are the 
maximum and minimum response, respectively, x is the drug concentra-
tion, and p is the Hill coefficient. All data are given as mean ± SEM. Differ-
ences between groups were assessed by Student’s t test or 1-way ANOVA. 
The differences were considered significant at P ≤ 0.05.
Chemicals. Edelfosine was from Calbiochem; XE991 and ZD7288, from 
Tocris; Xe-C, from Cayman Europe; and fura-2AM, from Invitrogen. Reti-
gabine was a gift from Kewei Wang (Peking University, Beijing, China); all 
other chemicals were from Sigma-Aldrich.
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